ArticleScientific reports2024

Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.

Heba Effat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.